Syntacoll GmbH

Company

    • Company type:
      • Manufacturer
    • Year founded:
    • 1992
    • Employees (at the site):
    • 64
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Our lead pipeline products at advanced stages in clinical development include XaraColl in phase 3 for the treatment of post-operative pain, and Cogenzia in phase 3 for the treatment of diabetic foot infections. CollaGUARD, an adhesion barrier, is ready to enter a pivotal study required for approval in the United States.
      Collagen products ; Disposable articles, veterinary ; Sports medical physio-therapeutical preparations

    • Core competencies:
    • not available

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Prophylactic drug development
      • Biotechnology: Technical services for biotechnology
      • Biotechnology: Therapeutic drug development
      • Chemical Industry: Pharmaceutical preparations
      • Medical Technology: Veterinary medicine equipment and instruments
    • Industries NACE:
      • 18.12: Other printing
      • 17.29: Manufacture of other articles of paper and paperboard
      • 22.2: Manufacture of plastics products
      • 21: Manufacture of basic pharmaceutical products and pharmaceutical preparations
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Einhard Schmidt (Mr.)
      - Management